The Lancet Gets Research Wrong Again

 

Journalism credibility has taken a deep dive in the era of the Trump administration as liberal journalists lower their standards when covering a president they can’t tolerate. The New York Times has even admitted they have changed the rules when it comes to news concerning President Trump.

Now it seems this attitude even applies to medical research. The British medical journal The Lancet recently published a study suggesting the antimalaria drug hydroxychloroquine (HCL), which Trump has promoted and used, is dangerous. But now TheLancet is backpedaling as it becomes clear the research data for this study has been discredited.

Hydroxychloroquine has been in common use worldwide for over sixty years and has been safely used to treat malaria, rheumatoid arthritis, and lupus. When early studies in China showed no COVID-19 cases in patients who concurrently were taking HCL for lupus, doctors hypothesized it provided prophylactic protection. When other studies in France showed promising results, the FDA approved it for emergency use for COVID-19.

The Wall Street Journal editorial board say Democrats and the media assailed Trump for promoting “voodoo medicine” since randomized clinical trials have not confirmed HCL’s benefits. Senate Minority Leader Chuck Schumer attacked the Department of Veterans Affairs for launching clinical trials after a small study found 27.8% of veterans receiving the drug died compared to 11.2% who didn’t. But patients given HCL displayed much worse clinical vital signs including lower blood oxygen levels. VA Secretary Robert Wilkie has explained that “we used this in the last hours of a veteran’s life in the hopes it could prolong this life.”

Adding fuel to this political fire was the initial report of TheLancet, published May 22, that showed a 30% increase in mortality based on 96,032 COVID-19 patient records that the data company Surgisphere claimed to have collected from 671 hospitals on six continents. As a result, the World Health Organization halted its global HCL clinical trial and many countries banned the drug as a COVID-19 treatment.

But The Lancet study quickly came under fire when scientists around the world reviewed the data. They spotted glaring errors such as obesity and smoking rates in the study were the same across six continents. In a letter to TheLancet’s editors last week, 120 scientists criticized the study’s sloppiness and aggregation of patients who were different in many respects including HCL dosages and the severity of illness. The study also had not undergone an ethics review and The Lancet had broken its pledge to share all data and code on COVID-19 studies. Surgisphere is now under investigation concerning the sources of their data.

The Lancet recently published an “Expression of Concern” about the study and said it would undergo “an independent data audit.” If there is any doubt their work may be politically biased, one only has to read an editorial published by the Lancet editors last month urging Americans to vote out President Trump.

This is not the first time The Lancet has been at the center of controversial studies. In 1998, a British doctor, Andrew Wakefield, published an article in The Lancet. Wakefield did intestinal biopsies on 12 children with intestinal symptoms and developmental disorders, 10 of whom were autistic, and found intestinal inflammation. The parents of 8 of the autistic children believed their symptoms began after receiving the measles, mumps, and rubella (MMR) vaccine. The published paper clearly said, “We did not find an association between measles, mumps, and rubella vaccine and the syndrome described. Virologic studies are underway that may help to resolve this issue.”

However, despite this disclaimer in the paper, Wakefield held a press conference to say the MMR vaccine probably caused autism and he recommended stopping MMR vaccinations. Instead, he recommended giving the vaccinations separately at intervals of a year or more.

Wakefield’s analysis was thoroughly discredited later and he was found to have done questionable research on other subjects as well. The Lancet retracted his original paper. Richard Horton, editor of The Lancet, described the original paper as “fatally flawed” and apologized for publishing it. Ten of the original 12 co-authors published a retraction stating:

“We wish to make it clear that in this paper no causal link was established between the vaccine and autism, as the data were insufficient. However, the possibility of a link was raised, and consequent events have had major implications for public health. In view of this, we consider now is the appropriate time that we should together formally retract the interpretation placed upon these findings in the paper, according to precedent.”

 

The damage from this poorly vetted research continues today as many still believe autism is associated with vaccinations. The Lancet bears responsibility for this publishing malpractice. Now they have done it again, apparently due to their political bias. There is no place in medicine and medical research for political bias. Scientific research should be above the political world if we are ever to have faith in the accuracy of its conclusions. The Lancet has failed us again.

 

COVID-19 and the Nursing Home Disaster

 

Nursing homes are supposed to be places of refuge for those who need long-term medical care and support. They are home to some of our most vulnerable, usually elderly people. Sadly, they have become death traps for many, especially in some states.

Avik Roy, writing in Forbes, says 2.1 million Americans, representing 0.62% of our population, reside in nursing homes and assisted living facilities. In a recent analysis, performed by Roy and Gregg Girvan for the Foundation for Research and Equal Opportunity, they studied the number of nursing home-related deaths due to the COVID-19 virus. They found 42% of all deaths due to the virus, in the 43 states reporting figures, occurred in nursing homes and assisted living facilities.

42% of all COVID-19 deaths happened in facilities that house 0.6% of the population!

These astounding numbers are probably too conservative. In New York, the number of nursing home deaths was certainly under-reported since they chose to exclude any deaths of nursing home residents that occurred after transport to a hospital. Outside of New York, more than half of all deaths from COVID-19 are of residents of long-term care facilities.

Here are some states with the highest percentages:

  • Ohio – 70%
  • Pennsylvania – 69%
  • Minnesota – 81%
  • New Hampshire – 70%
  • Washington – 61%

Tragically, the decisions of state government officials greatly impacted these figures. In the states of New York, New Jersey, and Michigan, nursing homes were ordered to accept infected patients in transfer from hospitals after discharge. This may have been designed to prevent overcrowding of ICUs, but at the expense of nursing home residents.

New York Governor Andrew Cuomo was outspoken in defending this practice. As recently as April 23, Cuomo declared that nursing homes “don’t have the right to object” to accepting elderly patients with active COVID-19 infections. “That is the rule and that is the regulation and they have to comply with that,” said Cuomo. Only on May 10 – after the deaths of 3,000 New York residents in nursing homes – did Cuomo stand down and partially rescind his order.

Florida Did Better

Florida Governor Ron DeSantis required all nursing home workers to be screened for COVID-19 symptoms before entering the facilities. On March 15, DeSantis signed an executive order banning nursing home visitations by friends or family, and also banned hospitals from discharging patients who were infected with the virus to long-term care facilities.

Florida also prioritized long-term care facilities for personal protective equipment (PPE). DeSantis said, “If I can send PPE to the nursing homes, and they can prevent an outbreak there, that’s going to do more to lower the burden on hospitals than me just sending them another 500,000 N95 masks.”

Roy says we should all learn from the Florida experience. He recommends the following:

  • Rescind all state orders to mandate nursing homes accept infected patients
  • Restrict visits to nursing homes by friends and family until further notice
  • Prioritize PPE for nursing homes at least as high as hospitals
  • Test all nursing home workers for active infection
  • Limit nursing home workers to one facility when possible
  • Force those 7 states not reporting nursing home deaths to begin reporting

 

The Silver Lining

The silver lining in this story is that the 99.4% of the U.S. population that doesn’t live in nursing homes is roughly half as likely to die of this corona virus than we previously thought. These latest figures show a strong correlation with advancing age, other medical co-morbidities, and nursing home residence. Those who do not fit into these categories are at considerably lower risk.

 

If you’re one of the 99.4% of Americans who do not live in a nursing home, you should feel better. If you, or your loved ones, do live in a nursing home, you should insist they comply with the above recommendations whenever possible.

 

Biden’s Slippery Slope Toward Socialized Medicine

 

Joe Biden likes to promote himself as the moderate candidate. He has resisted pressure from progressives like Senator Bernie Sanders to endorse his Medicare for All plan, which is complete takeover of healthcare by the government and elimination of private health insurance.

But the old saying is, “the devil is in the details.” Biden is inching closer and closer to Sanders’ socialized medicine plan the longer he campaigns. The distinction between the two is getting slimmer and slimmer.

Biden began his campaign stressing he wanted to “protect and preserve ObamaCare.” Back then he wanted nothing to do with Medicare for All. Then he said he wanted to offer a “Public Option”, which would lead to socialized medicine eventually as the government-supported “Public Option” eliminated competition from the private insurance market gradually over time. I explained this in detail in Bernie v. Biden: Medicare for All Sooner or Later. 

Now Biden is taking his move to the left one step farther. Now he’s calling for “Medicare for More.” In this new proposal, Biden wants to reduce eligibility for Medicare from age 65 to age 60. There are multiple problems to this new approach.

Benedic Ippolito and Chris Pope, writing in The Wall Street Journal, say Biden’s plan relies on large cuts to hospital revenues that won’t fly in Congress, especially among Democrats. Moreover, his expansion is poorly designed if the goal is to help the uninsured. Lowering the age of Medicare to 60 would require heavy subsidies from taxpayers. Employers would be prohibited from dropping the newly eligible from their plans.

Currently, hospitals are effectively required to treat Medicare enrollees at rates averaging 59% less than what hospitals receive from employer-sponsored insurance plans. In 2015, adults 60 to 65 accounted for 6% of the U.S. population but 17% of costs paid by private insurers, according to the Department of Health and Human Services. This loss of revenue would seriously impact hospitals and probably lead to many of them closing. Of course, this same impact would be even greater with Medicare for All.

This push to reduce funding of hospitals goes counter to the prevailing Democratic Party leadership which is pushing efforts to expand hospital funding substantially after the Covid-19 pandemic. Republican efforts to end “surprise medical billing” were derailed by the prospect of payment reductions to hospitals.

Another issue is the impact on the uninsured. Currently only 8% of the 60 to 64 age population is uninsured. With this new Biden proposal, Americans would be asked to pick up the tab for those in this age group who are already covered – at a cost of roughly $250 billion a year currently paid by private insurance. Medicare outlays are already expected to double in the next decade and the program’s trust fund is projected to be insolvent in 2026.

This Biden proposal would be subsidizing the income of workers whose median household income was more than $92,000 in 2017. It would help the relatively affluent instead of devoting resources to the most needy. Of the 28.5 million Americans without insurance, only 1.6 million of those are in the 60 to 64 age group according to the Census Bureau.

Joe Biden may think this idea will get him more votes in November, but it won’t fix the flaws in Medicare or assist the families that need help the most. But it will be one step closer to Medicare for All.